| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 39.431 | 59.469 | 59.838 | 88.613 | 77.021 | 101.773 | 95.496 | 110.056 | 122.079 |
| Total Income - EUR | - | 39.431 | 59.469 | 59.838 | 89.227 | 83.223 | 101.773 | 104.016 | 133.873 | 123.387 |
| Total Expenses - EUR | - | 25.877 | 33.656 | 37.166 | 55.730 | 70.869 | 72.516 | 73.896 | 96.638 | 56.764 |
| Gross Profit/Loss - EUR | - | 13.554 | 25.814 | 22.672 | 33.498 | 12.355 | 29.256 | 30.120 | 37.236 | 66.623 |
| Net Profit/Loss - EUR | - | 12.372 | 23.070 | 22.073 | 32.612 | 11.585 | 28.238 | 29.166 | 36.013 | 63.116 |
| Employees | - | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Dorobantu Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 39.553 | 29.511 | 18.230 | 7.434 | 102.415 | 78.169 | 55.445 | 35.223 | 96.333 |
| Current Assets | - | 6.598 | 20.497 | 23.076 | 35.917 | 11.001 | 13.832 | 58.952 | 28.823 | 25.837 |
| Inventories | - | 2.780 | 3.969 | 7.096 | 3.897 | 1.850 | 440 | 30.979 | 229 | 963 |
| Receivables | - | 0 | 148 | 518 | 2.683 | 3.784 | 3.667 | 27.126 | 7.775 | 12.167 |
| Cash | - | 3.818 | 16.381 | 15.463 | 29.337 | 5.367 | 9.725 | 846 | 20.819 | 12.708 |
| Shareholders Funds | - | 12.416 | 23.123 | 22.979 | 32.662 | 11.613 | 28.670 | 29.599 | 36.444 | 63.545 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 34.344 | 26.885 | 18.327 | 10.688 | 101.803 | 63.331 | 83.759 | 27.297 | 58.847 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 1.038 | 304 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dorobantu Med Srl